View Older Stories View More Recent Stories

Jul 23, 2019 07:00AM Frequency Therapeutics Completes $62 Million Series C Financing
Jul 10, 2019 11:25AM Acutus Medical Announces Addition of Scott Huennekens as Executive Chairman of the Board
Jul 9, 2019 07:30AM REVOLUTION Medicines Closes $100 Million Financing to Advance Pipeline of Novel Therapies Addressing Frontier Targets in RAS-Dependent Cancers
Jul 8, 2019 08:00AM AdaptHealth to Become a Public Company via Business Combination With DFB Healthcare
Jun 26, 2019 07:30AM Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with Deerfield
Jun 25, 2019 09:00AM Frontier Medicines launches with $67 million to develop novel medicines that drug the "undruggable" targets driving human disease
Jun 20, 2019 11:12AM Acutus Medical Announces $170 Million in Financing
Jun 17, 2019 08:00AM Nuvo Pharmaceuticals™ Provides Corporate Update
Jun 5, 2019 08:00AM Columbia University and Deerfield Management Launch Hudson Heights Innovations
May 23, 2019 10:24AM Duchenne Muscular Dystrophy Prevalence Increases, While Incidence Remains Steady
May 19, 2019 07:00AM Schrödinger Announces Close of Latest Financing, Raising Total of $110 Million
May 15, 2019 04:52PM Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
May 14, 2019 07:00AM Nuvo Pharmaceuticals™ Announces 2019 First Quarter Results
May 2, 2019 06:33PM Aerie Pharmaceuticals Announces Additional Undrawn $100M Credit Facility with Deerfield Management, Increasing Availability to $200M
Apr 23, 2019 04:03PM NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million
Apr 23, 2019 04:03PM NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million
Apr 23, 2019 11:00AM UIC and Deerfield Management launch West Loop Innovations to foster development of new therapeutics
Apr 15, 2019 08:00AM Mirum Pharmaceuticals Presents New Data Demonstrating Durable Improvements in Clinical Outcome Measures in Patients with PFIC2 and Alagille Syndrome Treated with Maralixibat
Apr 8, 2019 09:30AM Vinson & Elkins Makes Significant Expansion in New York With Addition of Nationally Recognized Real Estate Team
Mar 29, 2019 07:00AM Nuvo Pharmaceuticals™ Announces 2018 Fourth Quarter and Year-End Results
Mar 27, 2019 08:00AM Mirum Pharmaceuticals to Present Phase 2 Clinical Results of Maralixibat in Alagille Syndrome and Progressive Familial Intrahepatic Cholestasis at the International Liver Congress
Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar 26, 2019 07:00AM Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
Mar 21, 2019 08:00AM Mirum Pharmaceuticals Appoints Chris Peetz as Chief Executive Officer
Mar 14, 2019 07:00AM Neos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
Mar 13, 2019 08:00AM Harvard and Deerfield Establish Lab1636, a Major Translational Research Alliance
Mar 13, 2019 08:00AM Harvard and Deerfield establish Lab1636, a major translational research alliance
Mar 13, 2019 07:30AM TriNetX Secures $40 Million in Series D Funding
Mar 11, 2019 08:00AM Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator
Mar 11, 2019 07:30AM Nuvo Pharmaceuticals™ Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible Notes and Warrants
Feb 27, 2019 10:15AM Itamar Medical to Commence Trading on Nasdaq
Feb 26, 2019 10:12AM Deerfield and Oxeon Join Forces with HLTH to Connect Healthcare Leaders with Qualified Female Board Candidates
Feb 25, 2019 08:15AM Melinta Therapeutics Announces Closing of Initial $75 Million Vatera Convertible Loan Funding
Feb 25, 2019 08:15AM Melinta Therapeutics Announces Closing of Initial $75 Million Vatera Convertible Loan Funding
Feb 21, 2019 01:31PM Melinta Therapeutics (MLNT) Board Approves 1-for-5 Reverse Stock Split
Feb 21, 2019 01:30PM Melinta Therapeutics Announces One-for-Five Reverse Stock Split
Feb 21, 2019 01:30PM Melinta Therapeutics Announces One-for-Five Reverse Stock Split
Feb 14, 2019 06:29PM Form 13F-HR DEERFIELD MANAGEMENT For: Dec 31
Feb 12, 2019 09:04AM Adeptus Health Appoints James Hopwood as its Chief Financial Officer
Feb 7, 2019 04:15PM Axovant Announces Third Fiscal Quarter 2018 Financial Results and Corporate Updates
Feb 6, 2019 08:00AM Deerfield Management Advanced Healthcare Initiatives Globally Through Academic Collaborations, Publications, and Philanthropy
Feb 4, 2019 06:00PM CathWorks Announces Completion of $30 Million Financing
Feb 4, 2019 08:07AM Melinta Therapeutics (MLNT) Provides Updates on Strategic Repositioning Initiatives, Cost Savings Outlook
Feb 4, 2019 08:00AM Melinta Therapeutics Provides Corporate Updates
Feb 4, 2019 08:00AM Melinta Therapeutics Provides Corporate Updates
Jan 17, 2019 09:00AM Itamar Medical Announces Definitive Agreements for $11.5 Million Private Placement
Jan 10, 2019 07:30AM FTI Consulting’s Corporate Finance & Restructuring Segment Wins Several Industry Awards
Jan 10, 2019 07:30AM FTI Consulting’s Corporate Finance & Restructuring Segment Wins Several Industry Awards
Jan 8, 2019 07:45AM Johnson & Johnson Innovation to Join NXT Biomedical Therapeutic Device Incubator to Accelerate Medical Device Innovation
Jan 8, 2019 05:00AM PQ Bypass Announces $60 Million Financing to Advance New Therapeutic Approach to Peripheral Arterial Disease
View More Recent Stories View Older Stories